Gilead Seeks Approval for Treatment of Genotypes 1-6
- Garde D. Gilead tees up another hep C combo for FDA review. Fierce Biotech. Published October 29, 2015. Accessed October 29, 2015.
- Gilead Submits New Drug Application to U.S. Food and Drug Administration for Fixed-Dose Combination of Sofosbuvir/Velpatasvir for Treatment of All Six Genotypes of Hepatitis C. Gilead Sciences. Published October 28, 2015. Accessed October 29, 2015.